On this episode, I talk with Matthew Stanley, D.O., a psychiatrist and clinical vice president of the behavioral health service line at Avera Health, based in Sioux Falls, S.D. He is chair-elect of AHA’s Behavioral Health Services Committee.

Matt and I talk about the impact that COVID-19 has had on people’s mental health and new ways to support increased access to behavioral health services across the care continuum. The Avera team has created an urgent care, walk-in opportunity for people to receive behavioral health care. Different from an emergency department and designed to be a “friendly place,” Matt said the idea is to “build out a full spectrum of care and have a single entry point to help consumers navigate and get to the right level of care at the right time for them, to resolve their behavioral health issues.”

We also discuss how hospitals and health systems can do a better job of integrating behavioral health care services and the reimbursement challenges they face.

I hope you find these conversations thought provoking and useful. Look for them once a month as part of the Chair File.


Watch the episode on YouTube.

Related News Articles

Headline
The Centers for Disease Control and Prevention last night endorsed Moderna’s COVID-19 vaccine for children aged 6-17, as its advisory committee…
Headline
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today unanimously recommended Moderna’s COVID-19 vaccine for…
Headline
The House last night voted 402-20 to pass the Restoring Hope for Mental Health and Well-being Act, bipartisan legislation that includes reauthorization through…
Blog
A recent article in the Washington Post “COVID bailout rescued some hospitals while enriching others” is wrong. The reality is that all of America’s hospitals…
Headline
Organizations can apply through July 29 for a portion of $10 million in funding to expand access to medication-assisted treatment for opioid use disorder in…
Headline
More than 1 million prescriptions for the COVID-19 antiviral pills Lagevrio and Paxlovid were dispensed between late December 2021 and May 2022, but dispensing…